These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blaschkitis under certolizumab for rheumatoid arthritis. Couderc M; Soubrier M Joint Bone Spine; 2014 Jul; 81(4):372-3. PubMed ID: 24439961 [No Abstract] [Full Text] [Related]
7. Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease. Mocciaro F; Orlando A; Renna S; Rizzuto MR; Cottone M J Crohns Colitis; 2011 Apr; 5(2):173-4. PubMed ID: 21453892 [No Abstract] [Full Text] [Related]
8. TNF inhibitors for Crohn's disease: when, which, and for how long. Med Lett Drugs Ther; 2013 Dec; 55(1432):102-3. PubMed ID: 24419244 [No Abstract] [Full Text] [Related]
9. Drug-induced erythema nodosum after the administration of certolizumab in Crohn's disease. Biedermann L; Kerl K; Rogler G; Hofbauer GF Inflamm Bowel Dis; 2013 Jan; 19(1):E4-6. PubMed ID: 22127817 [No Abstract] [Full Text] [Related]
10. Meningococcal meningoencephalitis after certolizumab pegol treatment in a patient with Crohn's disease. Majumder S; Kumar A J Crohns Colitis; 2013 Feb; 7(1):e19. PubMed ID: 22742971 [No Abstract] [Full Text] [Related]
11. Certolizumab pegol: new drug. As a last resort in Crohn's disease: continue to use other TNF alpha inhibitors. Prescrire Int; 2009 Jun; 18(101):108-10. PubMed ID: 19637418 [TBL] [Abstract][Full Text] [Related]
12. Certolizumab for rheumatoid arthritis. Markatseli TE; Papagoras C; Nikoli A; Voulgari PV; Drosos AA Clin Exp Rheumatol; 2014; 32(3):415-23. PubMed ID: 24447441 [TBL] [Abstract][Full Text] [Related]
13. Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol. Pasut G BioDrugs; 2014 Apr; 28 Suppl 1():S15-23. PubMed ID: 24687235 [TBL] [Abstract][Full Text] [Related]
14. How FABulous is PEGgy? Certoliziumab pegol from the bench to the patients. Aletaha D BioDrugs; 2014 Apr; 28 Suppl 1():S3-4. PubMed ID: 24687233 [No Abstract] [Full Text] [Related]
15. New drugs 09, part 2. Hussar DA Nursing; 2009 Jun; 39(6):33-9; quiz 40. PubMed ID: 19474606 [No Abstract] [Full Text] [Related]
16. Certolizumab pegol for the management of Crohn's disease in adults. Rivkin A Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385 [TBL] [Abstract][Full Text] [Related]
17. New drugs: Ciclesonide, certolizumab pegol, and bendamustine hydrochloride. Hussar DA J Am Pharm Assoc (2003); 2008; 48(4):557-61. PubMed ID: 18653436 [No Abstract] [Full Text] [Related]
19. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Smolen J; Landewé RB; Mease P; Brzezicki J; Mason D; Luijtens K; van Vollenhoven RF; Kavanaugh A; Schiff M; Burmester GR; Strand V; Vencovsky J; van der Heijde D Ann Rheum Dis; 2009 Jun; 68(6):797-804. PubMed ID: 19015207 [TBL] [Abstract][Full Text] [Related]
20. Seven new biologic agents approved in 2001. Piascik P J Am Pharm Assoc (Wash); 2002; 42(1):124-5. PubMed ID: 11833506 [No Abstract] [Full Text] [Related] [Next] [New Search]